Cala Health, a US-based medical device developer backed by healthcare group Johnson & Johnson and internet conglomerate Alphabet, has raised $18m in series A funding according to a regulatory filing on Tuesday.
Cala is working on therapies based on neuroscience discoveries from Stanford University, and more specifically a wearable treatment for hand tremor, according to MedCity News, which cited an alumni briefing from the Stanford Biodesign program.
The stealth-stage company has not revealed details of the funding but its website states its investors include Johnson & Johnson subsidiary Johnson & Johnson Development Corporation; GV, the Alphabet unit formerly known as Google Ventures; and DRX Capital, a joint venture between pharmaceutical firm Novartis and wireless technology producer Qualcomm.
The corporates are joined by Action Potential Venture Capital, Lux Capital and Lightstone Ventures.
– Photo courtesy of Cala Health